Codexis (CDXS) Capital Expenditures Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 227.76% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 0.57% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 143.40% |
| 10 | Codexis | 251.43 Mn | 186.29 Mn | 13.18 Mn | -91.51% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -91.51% |
| Dec 31, 2025 | -320.97% |
| Sep 30, 2025 | 121.38% |
| Jun 30, 2025 | -610.08% |
| Mar 31, 2025 | 458.76% |
| Dec 31, 2024 | 147.56% |
| Sep 30, 2024 | -59.60% |
| Jun 30, 2024 | 203.12% |
| Mar 31, 2024 | -54.70% |
| Dec 31, 2023 | -145.60% |
| Sep 30, 2023 | 163.23% |
| Jun 30, 2023 | -119.84% |
| Mar 31, 2023 | -83.91% |
| Dec 31, 2022 | 1,469.87% |
| Sep 30, 2022 | -195.97% |
| Jun 30, 2022 | 8.19% |
| Mar 31, 2022 | 99.57% |
| Dec 31, 2021 | -64.34% |
| Sep 30, 2021 | -1,271.86% |
| Jun 30, 2021 | 367.36% |
| Mar 31, 2021 | 235.09% |
| Dec 31, 2020 | 252.05% |
| Sep 30, 2020 | -90.33% |
| Jun 30, 2020 | -160.13% |
| Mar 31, 2020 | 435.92% |
| Dec 31, 2019 | 123.39% |
| Sep 30, 2019 | 241.69% |
| Jun 30, 2019 | -23.35% |
| Mar 31, 2019 | 787.50% |
| Dec 31, 2018 | -283.83% |
| Sep 30, 2018 | 4,400.00% |
| Jun 30, 2018 | 817.24% |
| Mar 31, 2018 | -93.25% |
| Dec 31, 2017 | 855.45% |
| Sep 30, 2017 | -104.47% |
| Jun 30, 2017 | -197.13% |
| Mar 31, 2017 | -10.57% |
| Dec 31, 2016 | -88.91% |
| Sep 30, 2016 | 198.10% |
| Jun 30, 2016 | 59.54% |
| Mar 31, 2016 | 409.62% |
| Dec 31, 2015 | 2,502.86% |
| Sep 30, 2015 | -32.69% |
| Jun 30, 2015 | 45.56% |
| Mar 31, 2015 | 147.62% |
| Dec 31, 2014 | -95.19% |
| Sep 30, 2014 | 180.41% |
| Jun 30, 2014 | -84.82% |
| Mar 31, 2014 | -56.25% |
| Dec 31, 2013 | 141.86% |
| Sep 30, 2013 | -339.51% |
| Jun 30, 2013 | 33.56% |
| Mar 31, 2013 | -97.72% |
| Dec 31, 2012 | -89.70% |
| Sep 30, 2012 | -97.77% |
| Jun 30, 2012 | -86.53% |
| Mar 31, 2012 | 136.48% |
| Dec 31, 2011 | 29.91% |
| Sep 30, 2011 | 134.24% |